US Federal Drug Authority gives anti-malaria drugs chloroquine emergency approval for COVID-19 treatment
COVID19 Updates- The USA Food and Drug Administration has issued a limited permit for emergency use of two antimalarial drugs to treat coronavirus patients by President Donald Trump
In a statement published on Sunday, the US Department of Health and Human Services examined recent donations of medicine to a national stockpile – including chloroquine and hydroxychlorine – as a treatment for COVID-19.
It told that FDA had allowed them “to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.”
Trump said last week that despite scientists warning against the dangers of over-the-counter treatment, these two drugs could be “God’s gift.”
Several researchers, including Anthony Fuqui, a leading infectious disease specialist in the United States, have urged the public to be vigilant until large clinical trials confirm small studies.
The National Institute of Health and the Biomedical Advanced Research and Development Authority are currently working to plan such trials.
Some scientists show concern over Trump’s endorsement of medicines that can lead to shortages for the patient who needs the medicine to treat lupus and rheumatoid arthritis diseases.
According to Johns Hopkins University, there are more than 140,000 novel coronavirus cases and 2,489 deaths in the United States.
